These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 15902335)
1. [Radiotherapy of intraocular tumors with Ruthenium-106-containing, beta-emitting ophthalmic applicators. Experiences with treatments performed between 1986 and 1999 in Hungary]. Berta A Magy Onkol; 2005; 49(1):53-7. PubMed ID: 15902335 [TBL] [Abstract][Full Text] [Related]
2. [Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)]. Lommatzsch PK; Weise B; Ballin R Klin Monbl Augenheilkd; 1986 Aug; 189(2):133-40. PubMed ID: 3761990 [TBL] [Abstract][Full Text] [Related]
3. On the actual state of industrial quality assurance procedures with regard to (106)Ru ophthalmic plaques. Kaulich TW; Zurheide J; Haug T; Budach W; Nüsslin F; Bamberg M Strahlenther Onkol; 2004 Jun; 180(6):358-64. PubMed ID: 15175870 [TBL] [Abstract][Full Text] [Related]
4. [Optimizing target volume assessment in irradiation of intraocular melanomas with ruthenium applicators]. Poier E; Langmann G; Leitner H; Vidic B Fortschr Ophthalmol; 1991; 88(2):158-60. PubMed ID: 1855736 [TBL] [Abstract][Full Text] [Related]
5. Results of contact beta-irradiation of choroidal melanomas. Damjanovich J; Berta A; Vezendi L Acta Chir Hung; 1997; 36(1-4):67-8. PubMed ID: 9408291 [TBL] [Abstract][Full Text] [Related]
6. Beta-ray brachytherapy with 106Ru plaques for retinoblastoma. Schueler AO; Flühs D; Anastassiou G; Jurklies C; Neuhäuser M; Schilling H; Bornfeld N; Sauerwein W Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1212-21. PubMed ID: 16682139 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60]. Bacin F; Rozan R; Donnarieix D; Dalens H Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952 [TBL] [Abstract][Full Text] [Related]
8. beta-Irradiation of retinoblastoma with 106Ru/106Rh applicators. Lommatzsch P Mod Probl Ophthalmol; 1977; 18():128-36. PubMed ID: 876042 [TBL] [Abstract][Full Text] [Related]
9. Malignant melanomas of the choroid and ruthenium applicators. Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116 [TBL] [Abstract][Full Text] [Related]
10. ¹⁰⁶Ruthenium plaque therapy (RPT) for retinoblastoma. Murakami N; Suzuki S; Ito Y; Yoshimura R; Inaba K; Kuroda Y; Morota M; Mayahara H; Sakudo M; Wakita A; Okamoto H; Sumi M; Kagami Y; Nakagawa K; Ohtomo K; Itami J Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):59-65. PubMed ID: 22575488 [TBL] [Abstract][Full Text] [Related]
13. [10 years' experience with ruthenium 106/rhodium 106 treatment of malignant melanoma of the choroid--report on 264 irradiated tumors]. Guthoff R; von Domarus D; Steinhorst U; Hallermann D Klin Monbl Augenheilkd; 1986 Jun; 188(6):576-83. PubMed ID: 3531691 [TBL] [Abstract][Full Text] [Related]
14. [Use of ruthenuim 106 in retinoblastoma treatment]. Pochop P; Malis J; Símová B; Malec J; Palkosková P Cesk Slov Oftalmol; 2005 May; 61(3):192-7. PubMed ID: 15984081 [TBL] [Abstract][Full Text] [Related]
15. Beta-ray brachytherapy of retinoblastoma: feasibility of a new small-sized ruthenium-106 plaque. Schueler AO; Flühs D; Anastassiou G; Jurklies C; Sauerwein W; Bornfeld N Ophthalmic Res; 2006; 38(1):8-12. PubMed ID: 16166817 [TBL] [Abstract][Full Text] [Related]
16. [A new way in the conservative therapy of intraocular tumors by means of beta-irradiation (Ruthenium 106) with preservation of vision]. Lommatzsch P; Vollmar R Klin Monbl Augenheilkd; 1966; 148(5):682-99. PubMed ID: 5996539 [No Abstract] [Full Text] [Related]
17. [Radiotherapy in the treatment of retinoblastoma: about 40 cases]. Frikha H; Chaari N; Nasr C; Bouguila H; Chebbi A; Bhouri L; Hentati D; Kochbati L; Besbes M; Rifi H; Oubiche F; Ayed S; Maalej M Cancer Radiother; 2009 Jan; 13(1):30-6. PubMed ID: 18790660 [TBL] [Abstract][Full Text] [Related]
18. [A procedure for the determination of dose performance of radioactive eye applicators (106-Ru/106-Rh) and their significance for indications and treatment in malignant choroid melanomas]. Menapace R; Binder W Klin Monbl Augenheilkd; 1985 Nov; 187(5):451-4. PubMed ID: 4087812 [TBL] [Abstract][Full Text] [Related]
19. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma]. Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823 [TBL] [Abstract][Full Text] [Related]